Cisplatin Treatment Options in Canada

A collection of 326 research studies where Cisplatin is the interventional treatment. These studies are located in the Canada . Cisplatin is used for conditions such as Head and Neck Cancer, Lung Cancer and Non-small Cell Lung Cancer.

Home

Canada

All Treatments

Cisplatin

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ Adenocarcinoma

NCT01404156

Completed

The best treatment for resectable esophageal or gastroesophageal adenocarcinoma is unknown. Although an operation to remove the esophagus is the most common treatment, previous studies have shown that patients live longer when either perioperative (before and after surgery) chemotherapy or preoperative (before surgery) chemotherapy plus radiation is given, compared to surgery alone. However it is unknown which of these treatments (perioperative chemotherapy or preoperative chemoradiation) is mor... Read More

Gender:

ALL

Ages:

Between 18 years and 99 years

Trial Updated:

08/26/2024

Locations: Health Sciences Centre / CancerCare Manitoba, Winnipeg, Manitoba +2 locations

Conditions: Esophageal Cancer, Adenocarcinoma, Esophageal, Adenocarcinoma, Gastroesophageal Junction

Learn More ›

Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCA

NCT06569225

Not Yet Recruiting

Biliary tract cancer is a highly aggressive and heterogeneous group of gastrointestinal cancers that arise from the intra- or extrahepatic bile ducts (CCA), or the gallbladder (GBC)(1-3). While it accounts for only 0.7% of all malignant tumors and 3% of all gastrointestinal malignancies in adults, both incidence and mortality are increasing. Biliary tract cancers usually present at an advanced stage, with only approximately 20% of patients being diagnosed with an early-stage disease (1, 2, 4). T... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/21/2024

Locations: University Health Network, Toronto General Hospital, Toronto, Ontario

Conditions: Cholangiocarcinoma Resectable

Learn More ›

Biomarkers of Response to Pembrolizumab Combined With Chemotherapy in Non-Small Cell Lung Cancer (KEYNOTE-782, MK-3475-782)

NCT03664024

Completed

Participants with Stage IV nonsquamous non-small cell lung cancer (NSCLC) without prior systemic treatment will be treated with standard of care pembrolizumab combined with platinum-doublet chemotherapy for 4 cycles, then pembrolizumab plus pemetrexed maintenance for up to 31 additional cycles. The platinum doublet would be pemetrexed plus the investigator's choice of either cisplatin or carboplatin. The primary objective is to evaluate if total baseline tumor mutation burden (TMB) in cell-free... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/29/2024

Locations: University Of Colorado ( Site 0908), Aurora, Colorado +14 locations

Conditions: Non-Small Cell Lung Cancer

Learn More ›

Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol

NCT02501954

Completed

To determine if treatment with cisplatin and radiation followed by carbo and taxol reduces the rate of recurrence when compared to sandwich therapy.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

07/22/2024

Locations: Greater Baltimore Medical Center, Baltimore, Maryland +6 locations

Conditions: Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage IIIA Uterine Corpus Cancer, Stage IIIB Uterine Corpus Cancer, Stage IIIC Uterine Corpus Cancer, Stage IVA Uterine Corpus Cancer

Learn More ›

Using ctDNA to Determine Therapies for Lung Cancer

NCT04966663

Recruiting

This is a study to look at whether the presence of circulating tumour DNA (ctDNA) in the blood can help to predict whether giving adjuvant treatment after surgery can decrease the chance of the cancer coming back in people with lung cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/18/2024

Locations: Princess Margaret Cancer Centre, Toronto, Ontario

Conditions: Non Small Cell Lung Cancer, Complete Surgical Resection, Circulating Tumor DNA

Learn More ›

Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

NCT01798004

Completed

This pilot clinical trial studies busulfan, melphalan, and stem cell transplant after chemotherapy in treating patients with newly diagnosed neuroblastoma that is likely to come back or spread. Giving chemotherapy to the entire body before a stem cell transplant stops the growth of tumor cells by stopping them from dividing or killing them. After treatment, stem cells are collected from the patient's blood and stored. More chemotherapy or radiation therapy is given to prepare the bone marrow for... Read More

Gender:

ALL

Ages:

30 years and below

Trial Updated:

07/03/2024

Locations: Children's Hospital of Alabama, Birmingham, Alabama +122 locations

Children's Hospital of Alabama, Birmingham, Alabama

Kaiser Permanente Downey Medical Center, Downey, California

City of Hope Comprehensive Cancer Center, Duarte, California

Loma Linda University Medical Center, Loma Linda, California

Children's Hospital Los Angeles, Los Angeles, California

UCSF Benioff Children's Hospital Oakland, Oakland, California

Kaiser Permanente-Oakland, Oakland, California

Children's Hospital of Orange County, Orange, California

Lucile Packard Children's Hospital Stanford University, Palo Alto, California

University of California Davis Comprehensive Cancer Center, Sacramento, California

Rady Children's Hospital - San Diego, San Diego, California

UCSF Medical Center-Parnassus, San Francisco, California

UCSF Medical Center-Mission Bay, San Francisco, California

Children's Hospital Colorado, Aurora, Colorado

Connecticut Children's Medical Center, Hartford, Connecticut

Alfred I duPont Hospital for Children, Wilmington, Delaware

MedStar Georgetown University Hospital, Washington, District of Columbia

Children's National Medical Center, Washington, District of Columbia

Lee Memorial Health System, Fort Myers, Florida

Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida

University of Florida Health Science Center - Gainesville, Gainesville, Florida

Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida

Nemours Children's Clinic-Jacksonville, Jacksonville, Florida

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida

Miami Cancer Institute, Miami, Florida

AdventHealth Orlando, Orlando, Florida

Nemours Children's Hospital, Orlando, Florida

Nemours Children's Clinic - Pensacola, Pensacola, Florida

Johns Hopkins All Children's Hospital, Saint Petersburg, Florida

Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida

Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia

Augusta University Medical Center, Augusta, Georgia

Memorial Health University Medical Center, Savannah, Georgia

Lurie Children's Hospital-Chicago, Chicago, Illinois

University of Illinois, Chicago, Illinois

University of Chicago Comprehensive Cancer Center, Chicago, Illinois

Loyola University Medical Center, Maywood, Illinois

Saint Jude Midwest Affiliate, Peoria, Illinois

Southern Illinois University School of Medicine, Springfield, Illinois

Riley Hospital for Children, Indianapolis, Indiana

Ascension Saint Vincent Indianapolis Hospital, Indianapolis, Indiana

Blank Children's Hospital, Des Moines, Iowa

University of Kentucky/Markey Cancer Center, Lexington, Kentucky

Norton Children's Hospital, Louisville, Kentucky

Children's Hospital New Orleans, New Orleans, Louisiana

Maine Children's Cancer Program, Scarborough, Maine

Sinai Hospital of Baltimore, Baltimore, Maryland

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland

Walter Reed National Military Medical Center, Bethesda, Maryland

Tufts Children's Hospital, Boston, Massachusetts

Massachusetts General Hospital Cancer Center, Boston, Massachusetts

Dana-Farber Cancer Institute, Boston, Massachusetts

C S Mott Children's Hospital, Ann Arbor, Michigan

Wayne State University/Karmanos Cancer Institute, Detroit, Michigan

Bronson Methodist Hospital, Kalamazoo, Michigan

Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota

University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota

Mayo Clinic in Rochester, Rochester, Minnesota

University of Mississippi Medical Center, Jackson, Mississippi

Columbia Regional, Columbia, Missouri

Children's Mercy Hospitals and Clinics, Kansas City, Missouri

Washington University School of Medicine, Saint Louis, Missouri

Mercy Hospital Saint Louis, Saint Louis, Missouri

Children's Hospital and Medical Center of Omaha, Omaha, Nebraska

University of Nebraska Medical Center, Omaha, Nebraska

Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada

Summerlin Hospital Medical Center, Las Vegas, Nevada

Nevada Cancer Research Foundation NCORP, Las Vegas, Nevada

Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire

Hackensack University Medical Center, Hackensack, New Jersey

Saint Barnabas Medical Center, Livingston, New Jersey

Morristown Medical Center, Morristown, New Jersey

Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey

Newark Beth Israel Medical Center, Newark, New Jersey

Saint Joseph's Regional Medical Center, Paterson, New Jersey

University of New Mexico Cancer Center, Albuquerque, New Mexico

Montefiore Medical Center - Moses Campus, Bronx, New York

NYU Langone Hospital - Long Island, Mineola, New York

The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York

University of Rochester, Rochester, New York

State University of New York Upstate Medical University, Syracuse, New York

Mission Hospital, Asheville, North Carolina

UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

Duke University Medical Center, Durham, North Carolina

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Rainbow Babies and Childrens Hospital, Cleveland, Ohio

Cleveland Clinic Foundation, Cleveland, Ohio

Nationwide Children's Hospital, Columbus, Ohio

Dayton Children's Hospital, Dayton, Ohio

ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio

Mercy Children's Hospital, Toledo, Ohio

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania

Medical University of South Carolina, Charleston, South Carolina

Prisma Health Richland Hospital, Columbia, South Carolina

BI-LO Charities Children's Cancer Center, Greenville, South Carolina

T C Thompson Children's Hospital, Chattanooga, Tennessee

East Tennessee Childrens Hospital, Knoxville, Tennessee

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee

UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas

Cook Children's Medical Center, Fort Worth, Texas

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas

Methodist Children's Hospital of South Texas, San Antonio, Texas

University of Texas Health Science Center at San Antonio, San Antonio, Texas

Naval Medical Center - Portsmouth, Portsmouth, Virginia

Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia

Seattle Children's Hospital, Seattle, Washington

Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington

University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin

Marshfield Medical Center-Marshfield, Marshfield, Wisconsin

Princess Margaret Hospital for Children, Perth, Western Australia

British Columbia Children's Hospital, Vancouver, British Columbia

CancerCare Manitoba, Winnipeg, Manitoba

IWK Health Centre, Halifax, Nova Scotia

McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario

Hospital for Sick Children, Toronto, Ontario

The Montreal Children's Hospital of the MUHC, Montreal, Quebec

Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec

CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL), Quebec, Not set

Starship Children's Hospital, Grafton, Auckland

Conditions: Stage 4S Neuroblastoma, Ganglioneuroblastoma, Stage 1 Neuroblastoma, Stage 2 Neuroblastoma, Stage 2A Neuroblastoma, Stage 2B Neuroblastoma, Stage 3 Neuroblastoma, Stage 4 Neuroblastoma

Learn More ›

A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer

NCT04025879

Active Not Recruiting

The main purpose of the study is to examine if periadjuvant (neoadjuvant, then adjuvant) immunotherapy will prolong event free survival in participants with early stage non-small cell lung cancer.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

06/26/2024

Locations: Local Institution - 0104, Tampa, Florida +107 locations

Local Institution - 0104, Tampa, Florida

Local Institution - 0040, Atlanta, Georgia

Local Institution - 0120, Augusta, Georgia

Local Institution - 0145, Chicago, Illinois

Local Institution - 0078, Chicago, Illinois

Local Institution - 0121, Orland Park, Illinois

Rcca Md Llc, Bethesda, Maryland

Local Institution - 0074, Boston, Massachusetts

Local Institution - 0076, Boston, Massachusetts

Local Institution - 0086, Traverse City, Michigan

Local Institution - 0100, Lebanon, New Hampshire

Local Institution - 0055, Cincinnati, Ohio

Local Institution - 0102, Cleveland, Ohio

Local Institution - 0054, Houston, Texas

Local Institution - 0103, Fredericksburg, Virginia

Local Institution - 0032, Ciudad Autonoma Beunos Aires, Buenos Aires

Local Institution - 0031, ABB, Ciudad Autónoma De Buenos Aires

Local Institution - 0043, Buenos Aires, Not set

Local Institution - 0030, Caba, Not set

Local Institution - 0020, Sydney, New South Wales

Local Institution - 0033, Heidelberg, Victoria

Local Institution - 0122, Melbourne, Victoria

Local Institution - 0023, North Ballarat, Victoria

Local Institution - 0002, Edegem, Not set

Local Institution - 0005, Liege, Not set

Local Institution - 0001, Roeselare, Not set

Local Institution - 0035, Belo Horizonte, Minas Gerais

Local Institution - 0029, Ijui, RIO Grande DO SUL

Local Institution - 0034, São Paulo, SAO Paulo

Local Institution - 0036, Sao Paulo, São Paulo

Local Institution - 0106, São Paulo, Not set

Local Institution - 0062, Oshawa, Ontario

Local Institution - 0115, Beijing, Beijing

Local Institution - 0096, Beijing, BEI

Local Institution - 0137, Fuzhou, Fujian

Local Institution - 0136, Fuzhou, Fujian

Local Institution - 0151, Hubei Sheng, Hubei

Local Institution - 0092, Changsha, Hunan

Local Institution - 0093, Changsha, Hunan

Local Institution - 0091, Changsha, Hunan

Local Institution - 0098, Shanghai, Shanghai

Local Institution - 0165, Shanghai, Shanghai

Local Institution - 0113, Shanghai, Shanghai

Local Institution - 0088, Chengdu, Sichuan

Local Institution - 0099, Hangzhou, Zhejiang

Local Institution - 0095, Shanghai, Not set

Local Institution - 0041, Praha 2, Not set

Local Institution - 0042, Praha 4, Not set

Local Institution - 0073, Besancon, Not set

Local Institution - 0037, La Tronche, Not set

Local Institution - 0050, Montpellier, Not set

Local Institution - 0038, Paris Cedex 18, Not set

Local Institution - 0051, Paris Cedex 20, Not set

Local Institution - 0083, Rennes Cedex 9, Not set

Local Institution - 0146, Rouen, Not set

Local Institution - 0110, Köln, Nordrhein-Westfalen

Local Institution - 0085, Berlin, Not set

Local Institution - 0065, Frankfurt, Not set

Local Institution - 0072, Georgsmarienhuette, Not set

Local Institution - 0071, Hamm, Not set

Local Institution - 0108, Heidelberg, Not set

Local Institution - 0109, Immenstadt, Not set

Local Institution - 0064, Loewenstein, Not set

Local Institution - 0147, Ludwigsburg, Not set

Local Institution - 0063, Luebeck, Not set

Local Institution - 0070, Moers, Not set

Local Institution - 0066, Muenchen, Not set

Local Institution - 0016, Dublin, Not set

Local Institution - 0024, Forlì, Not set

Local Institution - 0026, Milano, Not set

Azienda Ospedaliera Di Parma, Parma, Not set

Local Institution - 0135, Nagoya-shi, Aichi

Local Institution - 0124, Kashiwa-shi, Chiba

Local Institution - 0129, Kitakyushu-shi, Fukuoka

Local Institution - 0127, Kobe-shi, Hyogo

Local Institution - 0144, Kanazawa-shi, Ishikawa

Local Institution - 0125, Yokohama, Kanagawa

Local Institution - 0131, Sendai-shi, Miyagi

Local Institution - 0126, Sakai-shi, Osaka

Local Institution - 0130, Kitaadachigun, Saitama

Local Institution - 0142, Bunkyo-ku, Tokyo

Local Institution - 0133, Bunkyo-ku, Tokyo

Local Institution - 0143, Chuo-ku, Tokyo

Local Institution - 0134, Chuo-ku, Tokyo

Local Institution - 0132, Fukushima-shi, Not set

Local Institution - 0128, Hiroshima, Not set

Local Institution - 0077, Guadalajara, Jalisco

Local Institution - 0027, Monterrey, Nuevo Leon

Local Institution - 0028, Chihuahua, Not set

Local Institution - 0004, Groningen, Not set

Local Institution - 0003, Rotterdam, Not set

Local Institution - 0049, Kraków, Małopolskie

Local Institution - 0117, Hato Rey, Not set

Local Institution - 0013, Cluj-Napoca, Cluj

Local Institution - 0011, Bucuresti, Not set

Local Institution - 0012, Floresti, Not set

Local Institution, Moscow, Not set

Local Institution, Saint-Petersburg, Not set

Local Institution, St. Petersburg, Not set

Local Institution - 0046, Madrid, Not set

Local Institution - 0044, Majadahonda - Madrid, Not set

Local Institution - 0045, Valencia, Not set

Local Institution - 0149, Kaohsiung City, Not set

Local Institution - 0119, Kaohsiung, Not set

Local Institution - 0116, New Taipei City, Not set

Local Institution - 0112, Taipei City, Not set

Local Institution - 0007, Taunton, Not set

Conditions: Carcinoma, Non-Small-Cell Lung

Learn More ›

Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma

NCT02348216

Completed

This study will be separated into 3 distinct phases designated as the Phase 1 study, Phase 2 pivotal study (Cohort 1 and Cohort 2), and Phase 2 safety management study (Cohort 3 and Cohort 4, Cohort 5 and Cohort 6). The primary objectives of this study are: * Phase 1 Study: Evaluate the safety of axicabtagene ciloleucel regimens * Phase 2 Pivotal Study; Evaluate the efficacy of axicabtagene ciloleucel * Phase 2 Safety Management Study: Assess the impact of prophylactic regimens or earlier inte... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/31/2024

Locations: Banner MD Anderson Cancer Center, Gilbert, Arizona +35 locations

Banner MD Anderson Cancer Center, Gilbert, Arizona

City of Hope, Duarte, California

University of California San Diego (UCSD), La Jolla, California

Stanford University, Palo Alto, California

University of California Los Angeles (UCLA), Santa Monica, California

Sarah Cannon - Denver, Denver, Colorado

University of Miami, Miami, Florida

Moffitt Cancer Center, Tampa, Florida

Loyola University Medical Center, Maywood, Illinois

University of Iowa Hospitals and Clinics, Iowa City, Iowa

Dana Farber Cancer Institute, Boston, Massachusetts

Karmanos Cancer Center, Detroit, Michigan

Mayo Clinic, Rochester, Minnesota

Washington University School of Medicine, Saint Louis, Missouri

University of Nebraska, Omaha, Nebraska

Hackensack University Medical Center, Hackensack, New Jersey

Montefiore Medical Center, Bronx, New York

University of Rochester, Rochester, New York

Cleveland Clinic - Taussig Cancer Institute, Cleveland, Ohio

Sarah Cannon - Tennesee, Nashville, Tennessee

Vanderbilt University, Nashville, Tennessee

MD Anderson Cancer Center, Houston, Texas

Sarah Cannon-Methodist Healthcare System - San Antonio, San Antonio, Texas

Vancouver General Hospital, Vancouver, British Columbia

Princess Margaret, Toronto, Ontario

Hopital Saint Louis, Paris, Not set

Hopital Haut-Leveque, Pessac, Not set

CHU de Rennes, Rennes, Not set

Universitätsklinik Dresden, Dresden, Not set

University Hospital of Essen, Essen, Not set

Universitaetsklinikum Wuerzburg, Würzburg, Not set

Tel Aviv Souraski Medical Center, Tel Aviv, Not set

Academisch Medisch Centrum, Amsterdam, Not set

University Medical Center Groningen, Groningen, Not set

Erasmus MC, Rotterdam, Not set

University Medical Center Utrecht, Utrecht, Not set

Conditions: Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma (TFL), Primary Mediastinal B-cell Lymphoma (PMBCL), High Grade B-cell Lymphoma (HGBCL)

Learn More ›

Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations

NCT03773302

Terminated

Infigratinib is an oral drug which selectively binds to fibroblast growth factor receptor (FGFR) 2 and is being developed to treat participants with FGFR2 mutated cholangiocarcinoma. The purpose of the study is to evaluate the efficacy and safety of the investigational agent oral infigratinib vs standard of care chemotherapy (gemcitabine plus cisplatin) in first-line treatment of participants with unresectable locally advanced or metastatic cholangiocarcinoma with FGFR2 fusion/rearrangement. Sub... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/15/2024

Locations: Banner MD Anderson Cancer Center, Gilbert, Arizona +115 locations

Banner MD Anderson Cancer Center, Gilbert, Arizona

University of Arizona, Tucson, Arizona

University of Arkansas for Medical Sciences, Little Rock, Arkansas

St. Joseph Heritage Healthcare, Fullerton, California

USC Norris Cancer Center, Los Angeles, California

University of California Los Angeles, Los Angeles, California

Florida Hospital Medical Group, Orlando, Florida

UF Health Cancer Center at Orlando Health, Orlando, Florida

Northwestern Memorial Hospital, Chicago, Illinois

University Medical Center - New Orleans, New Orleans, Louisiana

Frederick Regional Healthcare Systems/James M. Stockman Cancer Institute, Frederick, Maryland

Massachusetts General Hospital, Boston, Massachusetts

Barbara Ann Karmanos Cancer Institute - Lawrence and Idell Weisberg Cancer Treatment Center, Detroit, Michigan

Cancer and Hematology Centers of Western Michigan, Grand Rapids, Michigan

William Beaumont Hospital, Royal Oak, Michigan

NYU Langone Medical Center, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Levine Cancer Institute - Charlotte, Charlotte, North Carolina

University of Cincinnati Medical Center, Cincinnati, Ohio

Ohio State University Comprehensive Cancer Center, Columbus, Ohio

Charleston Oncology, Charleston, South Carolina

Parkland Health and Hospital System, Dallas, Texas

University of Texas Southwestern Medical Center, Dallas, Texas

University of Texas MD Anderson Cancer Center, Houston, Texas

Baylor College of Medicine, Houston, Texas

Chris O'Brien Lifehouse Hospital, Camperdown, New South Wales

Blacktown Hospital, Darlinghurst, New South Wales

Royal Adelaide Hospital, Adelaide, South Australia

Monash Medical Centre, Bentleigh East, Victoria

Peninsula & South Eastern Haematology and Oncology Group, Frankston, Victoria

St John of God Hospital Subiaco, Subiaco, Western Australia

Cliniques Universitaires Saint-Luc, Bruxelles, Brussels

Grand Hopital de Charleroi, Charleroi, Not set

Universitair Ziekenhuis Antwerpen, Edegem, Not set

Cross Cancer Institute, Edmonton, Alberta

Ottawa Hospital, Ottawa, Ontario

St. Josephs Health Centre, Toronto, Ontario

Jewish General Hospital, Montréal, Quebec

Peking University People's Hospital, Beijing, Not set

Beijing Cancer Hospital, Beijing, Not set

Peking University Third Hospital, Beijing, Not set

Hunan Cancer Hospital, Changsha, Not set

Guangzhou First People's Hospital, Guangzhou, Not set

Hubei Cancer Hospital, Hubei, Not set

Liaoning Cancer Hospital & Institute, Shenyang, Not set

The First Affiliated Hospital, Sun Yat-sen University, Zhongshan, Not set

Hopital Henri Mondor, Créteil, Val-de-Marne

CHRU Dijon, Dijon, Not set

Centre Georges-Francois Leclerc, Dijon, Not set

Hopital Claude Huriez Rue Michel Polonovski (CHRU) Lille, Lille, Not set

Groupement Hospitalier Edouard Herriot, Lyon, Not set

Hopital Nord Franche-Comte, Montbéliard, Not set

Groupe Hospitalier Archet I Et II, Nice, Not set

Hopital Cochin, Paris, Not set

Hôpital Saint Antoine, Paris, Not set

L'Institut Mutualiste Montsouris, Paris, Not set

Universitätsklinikum Tübingen, Tübingen, Baden-Wurttemberg

Klinikum rechts der Isar der Technischen Universität München, München, Bayern

Klinikum Dortmund gGmbH, Dortmund, Not set

University Clinic Heidelberg, Heidelberg, Not set

Azienda Socio Sanitaria Territoriale di Cremona (ASST), Cremona, Not set

Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST, Meldola, Not set

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Not set

ASST Grande Ospedale Metropolitano Niguarda, Milano, Not set

Istituto Oncologico Veneto - I.R.C.C.S., Padova, Not set

Policlinico Universitario Campus Biomedico Di Roma, Roma, Not set

Pusan National University Hospital, Pusan, Not set

Seoul National University Bundang Hospital, Seongnam-si, Not set

SMG - SNU Boramae Medical Center, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Seoul National University Hospital, Seoul, Not set

Severance Hospital Yonsei University Health System, Seoul, Not set

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Not set

Ajou University Hospital, Suwon-si, Not set

Hospital Beatriz Angelo, Loures, Lisboa

Hospital Garcia de Orta, Almada, Not set

Centro Hospitalar E Universitário de Coimbra EPE, Coimbra, Not set

Instituto Português de Oncologia Francisco Gentil Centro Regional de Oncologia de Coimbra EPE, Coimbra, Not set

Centro Hospitalar Lisboa Norte, E.P.E. - Hospital de Santa Maria, Lisboa, Not set

Hospital CUF Descobertas, Lisboa, Not set

Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon, Not set

Centro Hospitalar do Porto - Hospital de Santo António, Porto, Not set

Instituto Portugues de Oncologia Do Porto Francisco Gentil Epe - PPDS, Porto, Not set

Centro Hospitalar de São João, E.P.E., Porto, Not set

Hospital Oncologico, Puerto Rico Medical Center, Rio Piedras, Not set

Hospital Universitario Virgen Macarena, Sevilla, Andalucia

Hospital Universitario Miguel Servet, Zaragoza, Aragon

Complejo Asistencial Universitario de Salamanca - Hospital Clinico, Salamanca, Castilla Y Leon

Hospital Universitario Germans Trias i Pujol, Badalona, Cataluna

Instituto Catalan de Oncologio ICO I'Hospitalet, Barcelona, Cataluna

Hospital Universitario Vall d'Hebrón - PPDS, Barcelona, Not set

Hospital General Universitario Gregorio Maranon, Madrid, Not set

Hospital Universitario Ramon y Cajal, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario La Paz, Madrid, Not set

Hospital Universitario HM Sanchinarro - CIOCC, Madrid, Not set

Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Not set

National Cheng Kung University Hospital, Tainan City, Tainan

National Taiwan University Hospital - YunLin Branch, Huwei, Not set

Chang Gung Memorial Hospital - Kaohsiung, Kaohsiung, Not set

China Medical University Hospital, Taichung City, Not set

Chi Mei Hospital, Liouying, Tainan, Not set

Taipei Veterans General Hospital, Taipei, Not set

National Taiwan University Hospital, Taipei, Not set

Chang Gung Memorial Hospital, Linkou, Taoyuan City, Not set

Songklanagarind Hospital, Prince of Songkla University, Hat Yai, Songkla

Chulalongkorn University, Bangkok, Not set

Ramathibodi Hospital Mahidol University, Bangkok, Not set

Maharaj Nakorn Chiang Mai Chiang Mai University, Chiang Mai, Not set

Srinagarind Hospital, Khon Kaen, Not set

Naresuan University, Phitsanulok, Not set

Nottingham City Hospital, Nottingham, Nottinghamshire

Royal Marsden Hospital, Sutton, Surrey

The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral

Guys Hospital, London, Not set

The Christie NHS Foundation Trust - PPDS, Manchester, Not set

Conditions: Advanced Cholangiocarcinoma, FGFR2 Gene Mutation

Learn More ›

Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System

NCT00653068

Completed

This phase III trial studies the side effects of combination chemotherapy, 3-dimensional conformal radiation therapy, and an autologous peripheral blood stem cell transplant, and to see how well they work in treating young patients with atypical teratoid/rhabdoid tumor of the central nervous system. Giving high-dose chemotherapy before an autologous peripheral blood stem cell transplant stops the growth of cancer cells by stopping them from dividing or killing them. Giving colony-stimulating fac... Read More

Gender:

ALL

Ages:

21 years and below

Trial Updated:

04/03/2024

Locations: Children's Hospital of Alabama, Birmingham, Alabama +93 locations

Children's Hospital of Alabama, Birmingham, Alabama

University of Alabama at Birmingham Cancer Center, Birmingham, Alabama

University of Arkansas for Medical Sciences, Little Rock, Arkansas

Kaiser Permanente Downey Medical Center, Downey, California

Miller Children's and Women's Hospital Long Beach, Long Beach, California

Children's Hospital Los Angeles, Los Angeles, California

Valley Children's Hospital, Madera, California

UCSF Benioff Children's Hospital Oakland, Oakland, California

Children's Hospital of Orange County, Orange, California

Rady Children's Hospital - San Diego, San Diego, California

UCSF Medical Center-Parnassus, San Francisco, California

UCSF Medical Center-Mission Bay, San Francisco, California

Connecticut Children's Medical Center, Hartford, Connecticut

Alfred I duPont Hospital for Children, Wilmington, Delaware

Children's National Medical Center, Washington, District of Columbia

Lee Memorial Health System, Fort Myers, Florida

Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida

University of Florida Health Science Center - Gainesville, Gainesville, Florida

Nemours Children's Clinic-Jacksonville, Jacksonville, Florida

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida

AdventHealth Orlando, Orlando, Florida

Nemours Children's Clinic - Orlando, Orlando, Florida

Orlando Health Cancer Institute, Orlando, Florida

Nemours Children's Clinic - Pensacola, Pensacola, Florida

Johns Hopkins All Children's Hospital, Saint Petersburg, Florida

Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida

Saint Mary's Hospital, West Palm Beach, Florida

Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia

University of Hawaii Cancer Center, Honolulu, Hawaii

Lurie Children's Hospital-Chicago, Chicago, Illinois

University of Chicago Comprehensive Cancer Center, Chicago, Illinois

Loyola University Medical Center, Maywood, Illinois

Riley Hospital for Children, Indianapolis, Indiana

University of Kentucky/Markey Cancer Center, Lexington, Kentucky

Norton Children's Hospital, Louisville, Kentucky

Tulane University School of Medicine, New Orleans, Louisiana

Children's Hospital New Orleans, New Orleans, Louisiana

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland

Walter Reed National Military Medical Center, Bethesda, Maryland

Dana-Farber Cancer Institute, Boston, Massachusetts

Wayne State University/Karmanos Cancer Institute, Detroit, Michigan

Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota

Mayo Clinic in Rochester, Rochester, Minnesota

University of Mississippi Medical Center, Jackson, Mississippi

Children's Mercy Hospitals and Clinics, Kansas City, Missouri

Washington University School of Medicine, Saint Louis, Missouri

Children's Hospital and Medical Center of Omaha, Omaha, Nebraska

Hackensack University Medical Center, Hackensack, New Jersey

Morristown Medical Center, Morristown, New Jersey

Saint Joseph's Regional Medical Center, Paterson, New Jersey

Overlook Hospital, Summit, New Jersey

University of New Mexico Cancer Center, Albuquerque, New Mexico

Montefiore Medical Center - Moses Campus, Bronx, New York

Roswell Park Cancer Institute, Buffalo, New York

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

University of Rochester, Rochester, New York

New York Medical College, Valhalla, New York

Mission Hospital, Asheville, North Carolina

UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Rainbow Babies and Childrens Hospital, Cleveland, Ohio

Cleveland Clinic Foundation, Cleveland, Ohio

Nationwide Children's Hospital, Columbus, Ohio

Dayton Children's Hospital, Dayton, Ohio

Mercy Children's Hospital, Toledo, Ohio

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Penn State Children's Hospital, Hershey, Pennsylvania

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Rhode Island Hospital, Providence, Rhode Island

Medical University of South Carolina, Charleston, South Carolina

Prisma Health Richland Hospital, Columbia, South Carolina

BI-LO Charities Children's Cancer Center, Greenville, South Carolina

Greenville Cancer Treatment Center, Greenville, South Carolina

East Tennessee Childrens Hospital, Knoxville, Tennessee

Driscoll Children's Hospital, Corpus Christi, Texas

Cook Children's Medical Center, Fort Worth, Texas

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas

Methodist Children's Hospital of South Texas, San Antonio, Texas

University of Texas Health Science Center at San Antonio, San Antonio, Texas

Primary Children's Hospital, Salt Lake City, Utah

Seattle Children's Hospital, Seattle, Washington

West Virginia University Charleston Division, Charleston, West Virginia

Marshfield Medical Center-Marshfield, Marshfield, Wisconsin

Children's Hospital of Wisconsin, Milwaukee, Wisconsin

Royal Children's Hospital, Parkville, Victoria

Princess Margaret Hospital for Children, Perth, Western Australia

Alberta Children's Hospital, Calgary, Alberta

McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario

Kingston Health Sciences Centre, Kingston, Ontario

Hospital for Sick Children, Toronto, Ontario

Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec

Conditions: Childhood Atypical Teratoid/Rhabdoid Tumor

Learn More ›

Intraperitoneal (IP) Cisplatin Given With Paclitaxel to Treat Epithelial Ovarian Cancer

NCT00889733

Terminated

The purpose of this study is to determine whether intraperitoneal (IP) Cisplatin combined with intravenous (IV) Paclitaxel is well tolerated in women with epithelial ovarian cancer who have had neoadjuvant chemotherapy followed by initial debulking surgery.

Gender:

FEMALE

Ages:

Between 18 years and 75 years

Trial Updated:

03/21/2024

Locations: University Health Network - Princess Margaret Hospital, Toronto, Ontario

Conditions: Epithelial Ovarian Cancer

Learn More ›

Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC

NCT02337530

Completed

The purpose of this study is to find out what effects a new drug, selumetinib, has on lung cancer when receiving standard chemotherapy with pemetrexed and platinum-based chemotherapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

03/19/2024

Locations: Tom Baker Cancer Centre, Calgary, Alberta +11 locations

Conditions: Non-Small Cell Lung Cancer

Learn More ›